Overview
Compounds in this area appear in the tissue-repair and recovery literature, often studied for angiogenesis, cytoprotection, and cell-migration signaling. The evidence base is predominantly preclinical, so this guide labels the study type for every cited claim and never reads animal or in-vitro data as human efficacy.
The Lys-Pro-Val tripeptide from the C-terminus of α-MSH, studied for anti-inflammatory signaling.
Evidence at a glance: Preclinical (animal) evidence
The cited evidence here is preclinical animal-model work, with limited or no human-trial data. Read the research profile accordingly.
Molecular identity
- Molecular formula
- C19H33N5O4
- Molecular weight
- 395.5 g/mol
- CAS number
- 67727-97-3
- Amino acids
- 3
- Appearance
- White lyophilized powder
- Purity (HPLC)
- 99%
Researched mechanism
Studied for anti-inflammatory activity via NF-κB modulation in epithelial and immune models.
Described as a mechanism characterized in the literature, not an effect you should expect from use.
What the published research shows
Anti-inflammatory effects in intestinal-inflammation models.
Honest note on evidence: Evidence is preclinical.
Every citation states its study type and population, so preclinical data is never presented as human-efficacy evidence.
How it compares
| Versus | Attribute | Note |
|---|---|---|
| BPC-157 | Focus | KPV is studied more narrowly for inflammation signaling. |
Reconstitution
Concentration math only: adding bacteriostatic water to the vial gives the resulting mg/mL shown below. This is not usage guidance.
| Vial | Bacteriostatic water | Concentration |
|---|---|---|
| 10 mg | 2 mL | 5 mg/mL |
Storage & stability
| State | Temperature | Duration |
|---|---|---|
| Lyophilized (unopened) | -20°C | 24 months |
| Reconstituted | 2–8°C | up to 4 weeks |
Common questions
Where does KPV come from?+
It is the C-terminal tripeptide of α-MSH; research isolates this fragment for its signaling profile.
